EUVIMEDEUVIMED entdecken
Open Access

Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer

Syim Salahuddin, Oded Cohen, Margaret Wu, Javier Perez Irizarry, Teresita Vega, Geliang Gan, Yanhong Deng, Natalia Isaeva, Manju Prasad, Kurt A Schalper, Saral Mehra, Wendell G Yarbrough und 1 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Syim Salahuddin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Papillomavirus Infections, Head and Neck Neoplasms, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head and neck squamous cell cancer (HNSCC) occurs at higher rates among persons with HIV (PWH). This study compares the impact of sociodemographic and clinicopathologic characteristics on outcomes among PWH-HNSCC compared with HNSCC patients without HIV.

Methods

Patient data from HNSCC individuals were collected at a single academic hospital center between 2002 and 2018. Forty-eight patients with HIV (HIV-HNSCC) and 2894 HNSCC patients without HIV were included. Multivariate analysis determined predictors of survival using Cox proportional hazards regression model. HIV-positive and -negative tumors were analyzed by quantitative immunofluorescence for expression of CD4, CD8, CD20 and PD-L1.

Results

HIV-HNSCC patients had a lower median overall survival than HNSCC patients without HIV (34 [18–84] vs 94 [86–103] months; P < .001). In multivariate analysis that included age, sex, race/ethnicity, stage, site, tobacco use, time to treatment initiation, and insurance status, HIV was an independent predictor of poorer survival, with a hazard ratio of 1.98 (95% CI: 1.32–2.97; P < .001). PWH with human papillomavirus (HPV)–positive oropharyngeal tumors also had worse prognosis than HPV-positive oropharyngeal tumors in the population without HIV (P < .001). The tumor microenvironment among HIV-HNSCC patients revealed lower intratumoral CD8 infiltration among HIV+ HPV+ tumors compared with HIV– HPV+ tumors (P = .04).

Conclusions

HIV-HNSCC patients had worse prognosis than the non-HIV population, with HIV being an independent predictor of poor clinical outcomes when accounting for important sociodemographic and clinicopathologic factors. Our findings highlight differences in tumor biology that require further detailed characterization in large cohorts and increased inclusion of PWH in immunotherapy trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellPapillomavirus InfectionsHead and Neck NeoplasmsOropharyngeal NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckHIVPrognosisTumor Microenvironment

Stichwörter der Autor:innen

HIV/HPV coinfectionhead and neck cancernon-AIDS-defining cancersurvivaltumor microenvironment

Autor:innen und Institutionen

  • Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Otolaryngology, Head and Neck Surgery, Soroka Medical Center, Scarsdale, New York, USA.
  • Department of Pediatrics, Northwestern University, Chicago, Illinois, USA.
  • Yale Cancer Center, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Yale Center for Analytic Sciences, Yale University School of Public Health, New Haven, Connecticut, USA.
  • Department of Otolaryngology/Head and Neck Surgery and Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institutes of Health
  • Yale Cancer Center

Zitieren

APA

Salahuddin, S., Cohen, O., Wu, M., Perez Irizarry, J., Vega, T., Gan, G., Deng, Y., Isaeva, N., Prasad, M., Schalper, K. A., Mehra, S., Yarbrough, W. G., & Emu, B. (2023). Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac924

Vancouver

Salahuddin S, Cohen O, Wu M, Perez Irizarry J, Vega T, Gan G, et al. Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac924

BibTeX
@article{Salahuddin2023,
  author = {Salahuddin, Syim and Cohen, Oded and Wu, Margaret and Perez Irizarry, Javier and Vega, Teresita and Gan, Geliang and Deng, Yanhong and Isaeva, Natalia and Prasad, Manju and Schalper, Kurt A and Mehra, Saral and Yarbrough, Wendell G and Emu, Brinda},
  title = {Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac924}
}
Kostenlos starten →